Curvebeam Ai Ltd. · ASX:CVB
Curvebeam Ai — NWR Virtual Healthcare Conference March 2024
15 slides from Curvebeam Ai's conference presentation, Mar 21, 2024
Slide 1: NWR Virtual Healthcare Conference March 2024
For personal use only NWR VIRTUAL HEALTHCARE CONFERENCE March 2024
Slide 2: Disclaimer
DISCLAIMER Introduction or its directors and therefore any investment is considered to be speculative in nature. THIS DOCUMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, For personal use only DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA OR TO ANY
Slide 3: Investment Highlights
CurveBeam AI is a medical device company focused on commercialising For personal use only weight bearing CT scanners • First to market natural bilateral weight bearing CT scanners First to Market • HiRise CT provides in-office high-resolution 3D scans with AI aided clinical assessment (subject to re
Slide 4: CurveBeam AI Overview
Background • A joint not under its natural weight can look normal, yet the pain is real • Natural bilateral weight bearing helps to show what is really going on in a joint For personal use only CURVEBEAM AI CurveBeam AI’s differentiators OVERVIEW • Improves patient workflow in a group practice setti
Slide 5: CurveBeam AI CT Devices & AI Output
CurveBeam AI CT Devices & AI Output CurveBeam AI has a range of CT imaging devices with visualisation applications in orthopaedics and bone health For personal use only STRAXCORP – KEY POINTS ORTHOPAEDIC VISUALISATION & PLANNING BONE HEALTH CLINICAL AIDS What do we do? Addressing a major underserved
Slide 6: Large Market Opportunity & Adoption by Leading Customers
Large Market Opportunity & Adoption by Leading Customers For personal use only Potential US Addressable Market ~17,000+ potential Customers 3 installations (WBCT scanners only) 1 (A$b)2 Examples o Mayo Clinics (all 3 major locations) • Hospital Based Medium to large hospitals - can incorporate o NYU
Slide 7: Two Business Models
Two Business Models Existing reimbursement codes target an attractive business model for investors For personal use only 1. Present HiRise Business Model – Stryker sells HiRise for US$410,000 (circa A$630,000) Daily patient volume through a USA group surgeon office – CurveBeam AI transfers to Stryke
Slide 8: Land & Expand Commercialisation Strategy
Land & Expand Commercialisation Strategy Over 170 first & second-generation installations worldwide, CurveBeam AI is well placed to upgrade its global install base to For personal use only the HiRise for targeting high margin AI module revenue NORTH AMERICA EUROPE • ~17,000+ potential installations
Slide 9: Key US Revenue Driver and Growth Opportunity
Key US Revenue Driver and Growth Opportunity CurveBeam AI & Stryker Foot and Ankle (F&A) US Co-Marketing & Distribution Partnership For personal use only • US multinational Stryker Corporation is one of the world’s leading medical technology companies • HiRise units will be preloaded with Stryker Pr
Slide 10: BMD and OSSVIEW Overview
S TA G E 1 – S E C O N D F X B U S I N E S S M O D E L An over 60 yr old fracture patient suspected of fragility fracture goes to FLS – non-osteoporosis – Impact or Fragility Fx? AWS BMD and OSSVIEW Overview Proprietary SaaS solutions leverage CT scans generated from its HiRise device For personal u
Slide 11: Next Generation WBCT Platform: SKYRISE
Next Generation WBCT Platform: SKYRISE For personal use only SPINE & SHOULDER future applications being developed • Targeted AI for the spine – AI to target each vertebrae using an anatomical landmark recognition system – this way implants can be optimised to the right site & trajectory • SkyRise, i
Slide 12: Summary
Summary For personal use only • First to market bilateral weight bearing CT scans First to Market • HiRise CT provides in-office high-resolution 3D scans & AI aided clinical assessment (subject to regulatory clearance) • Large A$10b in device sales plus A$2.7b per annum in BMD Large TAM addressable
Slide 13: Key Investment Risks
KEY INVESTMENT RISKS Regulatory clearances Reimbursement availability Market acceptance For personal use only • The Group will require, and intends to apply for, • The commercial success of the Group’s products and • Sales of the Group’s products and services depends further regulatory clearances in
Slide 14: Key Investment Risks
KEY INVESTMENT RISKS Additional funding risk Cyber risk and data breach For personal use only • The Group may need to raise additional funds in • There is a risk that the measures that the Group the future to support its operations and business. takes to prevent data breaches may prove to be The Gro
Slide 15: Thank You
For personal use only THANK YOU
CurveBeam AI — NWR Virtual Healthcare Conference March 2024 on 6ix